Seer uses engineered nanoparticles with an automated assay solution to provide an unmatched combination of unbiased, deep, rapid, and scalable workflows to allow researchers to study the proteome

A protein engineering company that applies its CodeEvolver platform technology to create high-performing enzymes for improving the cost and quality of pharmaceuticals and food ingredients, to enable sequencing of minute quantities of DNA for medical diagnostics, and to create novel biotherapeutics.

Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. We use Centrellis, our unique advanced analytics platform, to build predictive models of human health to deliver personalized insights for patients in the areas of women’s health and precision oncology, as well as more generalized genomic health screening and modeling across the spectrum of disease.

No fundamentals data found for any of the summaryTypes=earnings

Signify is a value-based health care network that specializes in in-home care for all population segments.

	Weight Rank	Company	Ticker	Quote ($)	Weight	Market Cap	Ark Ownership %	Funds	Country

	1	Teladoc Health	TDOC	181.26	7.16%	$27.97b	2.45%	ARKKARKFARKWARKG	🇺🇸
	2	Exact Sciences Corp.	EXAS	125.54	4.97%	$21.23b	2.20%	ARKKARKG	🇺🇸
	3	Pacific Biosciences	PACB	32.16	4.94%	$6.04b	7.35%	ARKGARKK	🇺🇸
	4	Regeneron	REGN	475.17	4.7%	$50.91b	0.91%	ARKGARKK	🇺🇸
	5	Twist Bioscience	TWST	132.23	4.14%	$6.43b	6.19%	ARKKARKG	🇺🇸
	6	Novartis	NVS	87.55	3.98%	$197.09b	0.20%	ARKKARKG	🇨🇭
	7	Vertex Pharmaceuticals	VRTX	213.35	3.79%	$55.46b	0.67%	ARKG	🇺🇸
	8	Roche Holdings	RHHBY	41.93	3.52%	$287.79b	0.12%	ARKG	🇨🇭
	9	CareDx	CDNA	71.75	3.41%	$3.72b	8.70%	ARKG	🇺🇸
	10	Takeda Pharmaceutical Company	TAK	17.25	3.35%	$53.83b	0.60%	ARKG	🇯🇵
	11	Fate Therapeutics	FATE	77.99	3.13%	$7.31b	4.07%	ARKGARKK	🇺🇸
	12	10x Genomics	TXG	194.64	2.64%	$21.17b	1.66%	ARKGARKK	🇺🇸
	13	Accolade	ACCD	47.18	2.62%	$2.76b	9.22%	ARKG	🇺🇸
	14	Incyte Corporation	INCY	79.96	2.54%	$17.58b	1.38%	ARKG	🇺🇸
	15	Iovance Biotherapeutics	IOVA	30.19	2.52%	$4.44b	5.26%	ARKGARKK	🇺🇸
	16	CRISPR Therapeutics	CRSP	115.74	2.42%	$8.73b	2.58%	ARKGARKK	🇨🇭
	17	Veeva Systems	VEEV	264.23	2.32%	$40.22b	0.62%	ARKG	🇺🇸
	18	Ionis Pharmaceuticals	IONS	42.36	2.31%	$5.97b	3.69%	ARKG	🇺🇸
	19	Schrödinger, Inc.	SDGR	73.9	2.07%	$5.17b	4.60%	ARKG	🇺🇸
	20	Invitae Corporation	NVTA	38	2.06%	$7.47b	2.72%	ARKGARKK	🇺🇸
	21	Castle Biosciences	CSTL	69.51	1.93%	$1.74b	10.51%	ARKG	🇺🇸
	22	Pure Storage	PSTG	21.64	1.65%	$6.07b	2.61%	ARKWARKKARKG	🇺🇸
Featured Post: The Role of Pure Storage in Next Generation TechnologyTrading Floor
	23	Codexis	CDXS	24	1.62%	$1.55b	9.86%	ARKG	🇺🇸
	24	Adaptive Biotechnologies	ADPT	40.42	1.54%	$5.63b	2.52%	ARKG	🇺🇸
	25	Berkeley Lights	BLI		1.5%			ARKKARKG	🇺🇸
Featured Post: The Role of Berkeley Lights in Next Generation TechnologyTrading Floor
	26	Bristol Myers Squibb	BMY	62.61	1.42%	$139.87b	0.10%	ARKG	🇺🇸
	27	Beam Therapeutics	BEAM	70.23	1.41%	$4.33b	2.94%	ARKKARKG	🇺🇸
	28	Sarepta Therapeutics	SRPT	70.54	1.4%	$5.60b	2.37%	ARKG	🇺🇸
	29	Intellia Therapeutics	NTLA	70.64	1.39%	$4.78b	2.70%	ARKGARKK	🇺🇸
	30	Personalis	PSNL	23.02	1.36%	$1.01b	12.94%	ARKG	🇺🇸

Cathie's Ark

Ark Invest Fund Holdings

All 55 ARKG ETF Holdings

Updated daily, these are the positions, trades, and weight of all companies in ARKG

All Filters

ARKG Timeline

Newly opened and closed positions within the past 60 trading sessions

ABBV

Started on February 16th 2021

at a 0.1% weighting

CMLF

Started on February 11th 2021

at a 0.27% weighting

HIMS

Started on January 27th 2021

at a 0.11% weighting

ONEM

Started on January 19th 2021

at a 0.08% weighting

BMY

Started on January 11th 2021

at a 0.48% weighting

VEEV

Started on December 22nd 2020

at a 0.54% weighting

MASS

Started on December 18th 2020

at a 0.27% weighting

SRPT

Started on December 10th 2020

at a 0.02% weighting

GOOGL

Started on November 30th 2020

at a 0.48% weighting

RHHBY

Started on November 30th 2020

at a 0.14% weighting

ARKG Key Metrics

Aggregate measures for ARKG: Price To Sales, Earnings, and Revenue